BIOMARKER:

MET amplification + MET Exon 14 mutation

Entrez ID:

Related biomarkers:

‹

›

MET amplification + MET Exon 14 mutation MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer NSCLC	MET amplification + MET Exon 14 mutation MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer NSCLC	crizotinib Sensitive: C2 – Inclusion Criteria	crizotinib Sensitive: C2 – Inclusion Criteria
MET amplification + MET Exon 14 mutation MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma LUAD	MET amplification + MET Exon 14 mutation MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma LUAD	savolitinib Sensitive: C4 – Case Studies	savolitinib Sensitive: C4 – Case Studies